Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP207937.RASBv_lKPPPr-7LsmCzMSeiO83hKYHD71Ed4YCHfaPeqo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP207937.RASBv_lKPPPr-7LsmCzMSeiO83hKYHD71Ed4YCHfaPeqo130_assertion type Assertion NP207937.RASBv_lKPPPr-7LsmCzMSeiO83hKYHD71Ed4YCHfaPeqo130_head.
- NP207937.RASBv_lKPPPr-7LsmCzMSeiO83hKYHD71Ed4YCHfaPeqo130_assertion wasGeneratedBy ECO_0000203 NP207937.RASBv_lKPPPr-7LsmCzMSeiO83hKYHD71Ed4YCHfaPeqo130_provenance.
- NP207937.RASBv_lKPPPr-7LsmCzMSeiO83hKYHD71Ed4YCHfaPeqo130_assertion wasDerivedFrom befree-20140225 NP207937.RASBv_lKPPPr-7LsmCzMSeiO83hKYHD71Ed4YCHfaPeqo130_provenance.
- NP207937.RASBv_lKPPPr-7LsmCzMSeiO83hKYHD71Ed4YCHfaPeqo130_assertion SIO_000772 20610569 NP207937.RASBv_lKPPPr-7LsmCzMSeiO83hKYHD71Ed4YCHfaPeqo130_provenance.
- NP207937.RASBv_lKPPPr-7LsmCzMSeiO83hKYHD71Ed4YCHfaPeqo130_assertion evidence source_evidence_literature NP207937.RASBv_lKPPPr-7LsmCzMSeiO83hKYHD71Ed4YCHfaPeqo130_provenance.
- NP207937.RASBv_lKPPPr-7LsmCzMSeiO83hKYHD71Ed4YCHfaPeqo130_assertion description "[To elucidate whether systemic administration of CNP would be a novel medical treatment for chondrodysplasias, for which no drug therapy has yet been developed, we investigated the effect of circulating CNP by using the CNP transgenic mice with an increased circulating CNP under the control of human serum amyloid P component promoter (SAP-Nppc-Tg mice).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP207937.RASBv_lKPPPr-7LsmCzMSeiO83hKYHD71Ed4YCHfaPeqo130_provenance.